Magenta Therapeutics (MGTA) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction
All stock predictions
All currency forecasts
All cryptocurrency predictions

This Month Predictions for MGTA stock
Magenta Therapeutics, Inc. Analysis
MGTA Stock News


Popular stocks:
Vale S.A.
NVIDIA
Alibaba
Boeing
TAL Education
Quantum Computing
Suncor Energy
Shopify
BigBear.ai
Tilray

TOP Stocks:
Microsoft
Apple
Tesla
Alibaba
Amazon
American Airlines
NVIDIA
Adobe

Shares of other companies:
F5
Altria Group
Aadi Bioscience
The Bank of Nova Scotia
News
Suncor Energy
Applied Blockchain
Aerie Pharmaceuticals
PubMatic
Lyft


Financial News

Popular Stocks Analysis

Investor's Journal
Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…
Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…
Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

The launch of spot Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs) in January 2025 marked a turning point in the cryptocurrency market. These ETFs…
  1. Home
    2. »
  2. Stock forecasts
    3. »
  3. MGTA

Magenta Therapeutics (MGTA) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: March 22, 2025 (23:13)

Sector: Healthcare

The share price of Magenta Therapeutics, Inc. (MGTA) now

This company is DELISTED
Latest session on the 11th of September for
Magenta Therapeutics, Inc. is negative
Trading Volume: 376060
Open: 0.709 /  High: 0.759 /  Low: 0.681
Current value: $0.7

Are you interested in Magenta Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Magenta Therapeutics stock price in 2025, 2026, 2027. How much will one Magenta Therapeutics share be worth in 2025 - 2027?

When should I take profit in Magenta Therapeutics stock? When should I record a loss on Magenta Therapeutics stock? What are analysts' forecasts for Magenta Therapeutics stock? What is the future of Magenta Therapeutics stock? We forecast Magenta Therapeutics stock performance using neural networks based on historical data on Magenta Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Magenta Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Magenta Therapeutics shares. This happens once a day.


Historical and forecast chart of Magenta Therapeutics stock

The chart below shows the historical price of Magenta Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Magenta Therapeutics stock price can be found in the table below.

No data

Long-term forecasts by years.

Magenta Therapeutics, Inc. is a clinical stage biotechnology company that develops new drugs for bone marrow transplantation. It offers a platform that focuses on critical areas of transplantation. The company was founded by David Scudden, Derrick Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner in June 2015 and is headquartered in Cambridge, Massachusetts.

Trending Themes in the Healthcare Sector

Magenta Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Mar 24 0.71 0.71 0.73 3.18
Mar 25 0.72 0.71 0.73 3.05
Mar 26 0.71 0.70 0.73 4.55
Mar 27 0.69 0.68 0.70 2.62
Mar 28 0.71 0.70 0.72 3.91
Mar 29 0.73 0.71 0.74 3.46
Mar 30 0.72 0.71 0.74 4.58
Mar 31 0.72 0.71 0.73 2.48
Apr 01 0.71 0.70 0.72 2.72
Apr 02 0.72 0.70 0.72 2.78
Apr 03 0.72 0.70 0.73 4.49
Apr 04 0.74 0.73 0.75 2.58
Apr 05 0.75 0.73 0.76 3.71
Apr 06 0.76 0.75 0.77 3.05
Apr 07 0.76 0.74 0.77 3.23
Apr 08 0.76 0.75 0.78 3.14
Apr 09 0.76 0.75 0.77 2.43
Apr 10 0.77 0.77 0.79 2.66
Apr 11 0.76 0.75 0.77 2.99
Apr 12 0.75 0.74 0.76 2.61
Apr 13 0.74 0.73 0.75 3.00
Apr 14 0.73 0.72 0.74 2.16
Apr 15 0.72 0.71 0.73 2.90
Apr 16 0.73 0.72 0.73 1.27
Apr 17 0.75 0.73 0.76 4.76
Apr 18 0.74 0.72 0.76 4.35
Apr 19 0.74 0.73 0.74 2.68
Apr 20 0.72 0.70 0.74 4.47
Apr 21 0.73 0.72 0.75 4.20
Apr 22 0.71 0.71 0.72 1.76

Magenta Therapeutics Daily Price Targets


Magenta Therapeutics Stock Forecast 03-24-2025.

Forecast target price for 03-24-2025: $0.71.
Positive dynamics for Magenta Therapeutics shares will prevail with possible volatility of 3.082%.
Pessimistic target level: 0.71
Optimistic target level: 0.73

Magenta Therapeutics Stock Forecast 03-25-2025.

Forecast target price for 03-25-2025: $0.72.
Positive dynamics for Magenta Therapeutics shares will prevail with possible volatility of 2.962%.
Pessimistic target level: 0.71
Optimistic target level: 0.73

Magenta Therapeutics Stock Forecast 03-26-2025.

Forecast target price for 03-26-2025: $0.71.
Negative dynamics for Magenta Therapeutics shares will prevail with possible volatility of 4.347%.
Pessimistic target level: 0.70
Optimistic target level: 0.73

Magenta Therapeutics Stock Forecast 03-27-2025.

Forecast target price for 03-27-2025: $0.69.
Negative dynamics for Magenta Therapeutics shares will prevail with possible volatility of 2.558%.
Pessimistic target level: 0.68
Optimistic target level: 0.70

Magenta Therapeutics Stock Forecast 03-28-2025.

Forecast target price for 03-28-2025: $0.71.
Positive dynamics for Magenta Therapeutics shares will prevail with possible volatility of 3.760%.
Pessimistic target level: 0.70
Optimistic target level: 0.72

Magenta Therapeutics Stock Forecast 03-29-2025.

Forecast target price for 03-29-2025: $0.73.
Positive dynamics for Magenta Therapeutics shares will prevail with possible volatility of 3.349%.
Pessimistic target level: 0.71
Optimistic target level: 0.74

MGTA (MGTA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Apr. 0.73 0.68 0.78 12.89
May. 0.79 0.75 0.82 8.68
Jun. 0.78 0.71 0.81 12.10
Jul. 0.70 0.68 0.76 11.11
Aug. 0.62 0.57 0.64 11.65
Sep. 0.69 0.65 0.72 9.68
Oct. 0.65 0.60 0.67 10.86
Nov. 0.68 0.63 0.73 13.02
Dec. 0.69 0.64 0.74 14.14
Full forecast for 2025

Magenta Therapeutics forecast for this year


Magenta Therapeutics Stock Prediction for Apr 2025

An uptrend is forecast for this month with an optimal target price of $0.726884. Pessimistic: $0.68. Optimistic: $0.78


Magenta Therapeutics Stock Prediction for May 2025

An uptrend is forecast for this month with an optimal target price of $0.793031. Pessimistic: $0.75. Optimistic: $0.82


Magenta Therapeutics Stock Prediction for Jun 2025

An downtrend is forecast for this month with an optimal target price of $0.784783. Pessimistic: $0.71. Optimistic: $0.81


Magenta Therapeutics Stock Prediction for Jul 2025

An downtrend is forecast for this month with an optimal target price of $0.699085. Pessimistic: $0.68. Optimistic: $0.76


Magenta Therapeutics Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $0.616383. Pessimistic: $0.57. Optimistic: $0.64


Magenta Therapeutics Stock Prediction for Sep 2025

An uptrend is forecast for this month with an optimal target price of $0.691705. Pessimistic: $0.65. Optimistic: $0.72


Magenta Therapeutics Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $0.65214. Pessimistic: $0.60. Optimistic: $0.67


Magenta Therapeutics Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $0.675878. Pessimistic: $0.63. Optimistic: $0.73


Magenta Therapeutics Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $0.686421. Pessimistic: $0.64. Optimistic: $0.74



Magenta Therapeutics (MGTA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 0.77 0.69 0.85 18.53
Feb 0.77 0.70 0.79 11.71
Mar 0.71 0.66 0.77 13.29
Apr 0.73 0.65 0.76 14.07
May 0.81 0.77 0.84 8.46
Jun 0.77 0.73 0.81 10.08
Jul 0.84 0.81 0.90 10.31
Aug 0.82 0.76 0.89 15.43
Sep 0.88 0.85 0.96 11.29
Oct 0.86 0.79 0.93 14.35
Nov 0.91 0.83 0.95 12.37
Dec 0.85 0.77 0.90 14.51
Full forecast for 2026

Magenta Therapeutics (MGTA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 0.89 0.83 0.95 12.16
Feb 0.79 0.75 0.85 11.23
Mar 0.84 0.76 0.87 13.34
Apr 0.81 0.73 0.83 11.87
May 0.83 0.80 0.88 9.07
Jun 0.77 0.73 0.80 8.86
Jul 0.77 0.74 0.83 11.61
Aug 0.69 0.65 0.73 10.31
Sep 0.64 0.60 0.68 11.05
Oct 0.61 0.59 0.65 9.04
Nov 0.66 0.61 0.70 12.77
Dec 0.68 0.65 0.74 12.15
Full forecast for 2027

Magenta Therapeutics information and performance

Magenta Therapeutics Address

N/A

Market Capitalization: N/A $

Market capitalization of the Magenta Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of MGTA shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Magenta Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Magenta Therapeutics Stock)

Should I Buy Magenta Therapeutics Shares in 2025 year?

The maximum forecasted share price for next year is $0.91, which is $0.21 higher than the current stock price. By investing in Magenta Therapeutics shares today for a one-year period, you could achieve a profit of 30.56%. With an investment horizon of up to two years, the target share price is $0.89. resulting in a profit of 27.10% ($0.19 per share).

Does Magenta Therapeutics pay dividends?

No, it does not

Which economic sector do Magenta Therapeutics's shares belong to?

Magenta Therapeutics's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Magenta Therapeutics's shares?

You can view all the stocks that are part of the same sector as Magenta Therapeutics's shares in the Healthcare section.


Related stocks from Healthcare sector

Boston Scientific Corp. (BSX)
DaVita Inc. (DVA)
Clarus Therapeutics Holdings, Inc. (CRXT)
Nano-X Imaging Ltd. (NNOX)
Aadi Bioscience, Inc. (AADI)
Altamira Therapeutics Ltd. (CYTO)
Anavex Life Sciences Corp. (AVXL)
Magenta Therapeutics, Inc. (MGTA)
Alkermes plc (ALKS)
OrganiGram Holdings Inc. (OGI)


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.